Dynamic Standing Desk for Parkinson's (NCT07543861)
Improve walking with dynamic standing
- Trial ID
- NCT07543861
- Official Title
- A Pilot Study of In-lab Dynamic Standing in Parkinson's Disease
- Goal
- Improve walking with dynamic standing
- Phase
- PHASE1
- Status
- RECRUITING
- Sponsor
- University of Michigan
- Study Type
- INTERVENTIONAL
- Enrollment
- 5 participants
- Conditions
- Parkinson Disease
- Interventions
- Dynamic Standing Desk
Summary For Families
The goal is to see if short, supervised sessions of gentle movement while standing can safely engage postural muscles and help with stiffness, balance, or feeling faint when upright in people with Parkinson's. The approach uses a dynamic standing desk, a platform that provides small, controlled shifts in the standing surface to shift weight and activate leg and core muscles, which may boost circulation and postural control; it is a device intervention, not a drug, so it does not interact with levodopa. The trial is looking for adults age 50 and up with a Parkinson's diagnosis who can stand or walk without an assistive device, and it excludes people with significant orthostatic symptoms, serious heart or lung disease, recent stroke, active rheumatic disease, dementia (MoCA or MMSE under 24), disabling chronic pain on narcotics, severe varicosities or venous ulcers, pregnancy, or other major medical or psychiatric issues. It is a small, in-lab pilot enrolling about five participants to check safety and feasibility.
Locations
- Domino's Farms, Ann Arbor, Michigan, United States
Making Contact: How to Call This Study Site
Who to ask for
Ask for the study coordinator. Some sites call this person the research coordinator. They are the right person for questions about joining a study. If you reach a front desk or a doctor's office scheduler, ask them to connect you with the research team for this study.
What to say
It is fine to read this out loud, word for word:
Hello, my name is ____. I am calling about a Parkinson's study at your site. The study number is NCT07543861. It is the one about "Improve walking with dynamic standing". Could I speak with the study coordinator about taking part?
If you are calling for a family member, use their name and mention that you help with their care.
What they will ask you
- The year of diagnosis
- Current medications and their doses
- Other health conditions
- Any procedures already done, such as deep brain stimulation (DBS)
- How far you are able to travel for study visits
- Whether a care partner can come to visits with you
What to have ready
- A written list of current medications and doses
- Your neurologist's name and phone number
- The diagnosis date. The year is enough.
- A recent visit summary from the neurologist, if you have one
What to ask them
- How many visits are there, and how long does each visit take? The listing already answers this: Participants will attend up to 12 4-hour sessions plus a baseline and outcome assessment (up to 14 sessions total), and all sessions must be completed within 6 weeks. Ask the coordinator to confirm it still applies.
- Is travel, parking, or my time reimbursed?
- Is there a placebo group, and what is my chance of being in it? The listing already answers this: Everyone in this trial receives the experimental treatment. There is no placebo group. Ask the coordinator to confirm it still applies.
- Would I need to stop or pause any of my current medications?
- What happens when the study ends? Could I stay on the treatment if it helps?
What to expect
- Expect to wait a few days for a callback. A week is common. Calling or emailing again after that is fine and normal.
- Many callers do not end up joining. Screening out is common and is not a judgment about you or your health.
- Asking questions commits you to nothing. You can stop the process at any point.
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Dynamic Standing Desk. The goal is to see if short, supervised sessions of gentle movement while standing can safely engage postural muscles and help with stiffness, balance, or feeling faint when upright in people with Parkinson's. The approach uses a dynamic standing desk, a platform that provides small, controlled shifts in the standing surface to shift weight and activate leg and core muscles, which may boost circulation and postural control; it is a device intervention, not a drug, so it does not interact with levodopa. The trial is looking for adults age 50 and up with a Parkinson's diagnosis who can stand or walk without an assistive device, and it excludes people with significant orthostatic symptoms, serious heart or lung disease, recent stroke, active rheumatic disease, dementia (MoCA or MMSE under 24), disabling chronic pain on narcotics, severe varicosities or venous ulcers, pregnancy, or other major medical or psychiatric issues. It is a small, in-lab pilot enrolling about five participants to check safety and feasibility.
- Who can participate?
- Participants must be at least 50 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This Phase 1 trial is estimated to last approximately 11 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- Everyone in this trial receives the experimental treatment. There is no placebo group.
- How many visits does this trial involve?
- Participants will attend up to 12 4-hour sessions plus a baseline and outcome assessment (up to 14 sessions total), and all sessions must be completed within 6 weeks.